The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Russell Smith MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT01409798
First received: August 2, 2011
Last updated: May 11, 2016
Last verified: May 2016
  Purpose
The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.

Condition
Primary Hyperparathyroidism

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Enrollment: 175
Study Start Date: June 2010
Study Completion Date: November 2015
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Detailed Description:
This will be a multi-institutional prospective study in which patients that have undergone parathyroidectomy with intra-operative PTH assessment. The success of minimally invasive parathyroidectomy without and with intra-operative PTH will be assessed for each patient. Success for exploration without intra-operative PTH will be defined as directed exploration with detection of an abnormal parathyroid in the location suggested by imaging. Success with intra-operative PTH will be defined as per standard protocols (50% or > decrease in intra-operative PTH following excision).
  Eligibility

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Otolaryngology, Head and Neck Surgery clinic patients
Criteria

Inclusion Criteria:

  • Adult individuals (male and female) who have a personal diagnosis/history of primary hyperparathyroidism.
  • Age 19 or greater.
  • Patients who are seen and treated surgically at UNMC's Department of Otolaryngology- Head Neck Surgery .
  • Able to provide informed consent.

Exclusion Criteria:

-No history of primary hyperparathyroidism

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01409798

Locations
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
United States, Kansas
Kansas University Medical Center
Lawrence, Kansas, United States, 66160
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55414
United States, Missouri
University Of Missiouri
Columbia, Missouri, United States, 65212
United States, Nebraska
University of Nebraska Medical Center
Omaha,, Nebraska, United States, 681225
United States, South Dakota
Sanford School of Medicine
Sioux Falls, South Dakota, United States, 57105
Sponsors and Collaborators
University of Nebraska
Investigators
Principal Investigator: Russell B Smith, MD University of Nebraska
  More Information

Responsible Party: Russell Smith MD, Professor, Vice Chairman, University of Nebraska
ClinicalTrials.gov Identifier: NCT01409798     History of Changes
Other Study ID Numbers: 324-10-EP 
Study First Received: August 2, 2011
Last Updated: May 11, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
Hyperparathyroidism
Hypercalcemia

Additional relevant MeSH terms:
Hyperparathyroidism
Head and Neck Neoplasms
Hyperparathyroidism, Primary
Parathyroid Diseases
Endocrine System Diseases
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on August 22, 2016